缅北禁地

Hero

News & Events

缅北禁地 in the News
BioCentury Article:听缅北禁地: Attacking Tumors from Within

Fierce Biotech:

缅北禁地 Appoints Dr. Matthew Sleeman as Chief Scientific Officer

缅北禁地 Announces Licensing of a Novel Inflammatory Disease Target from its RAFT Platform

December 9, 2024

缅北禁地 Expands Leadership Team and Appoints Head of Development and General Counsel

November 13, 2024

缅北禁地 Announces License and Research Collaboration with MSD to Identify Novel Targets for Inflammatory Diseases

October 8, 2024

缅北禁地 Awarded Significant Grant from Innovate UK鈥檚 Prestigious Cancer Therapeutics Program to Accelerate the Path to the Clinic for MST-0300

August 28, 2024

View All Press Releases

J.P. Morgan 2026 Healthcare Conference – San Francisco, CA

January 12-15, 2026

Contact Us to Connect